Monthly Archives: January 2017


For Immediate Release: January 27, 2017
Contact: Benito Novas


Miami, US – Stem Cells Training, a subsidiary of Global Stem Cells Group that specializes in biotechnology training and teaching the latest techniques in stem cell medicine to qualified physicians and high level healthcare professionals, this week announced they will be holding two days of training at Hospital AXXIS on May 12th and 13th for all interested attendees.

As their sixth training in Ecuador, Stem Cells Training is planning to host four more sessions in Quito throughout this year.

“We offer a unique, comprehensive approach to training physicians in our courses and seminars based on world-class stem cell research, derived from our Global Stem Cells Group affiliation,” said Benito Novas, Founder and Owner of Stem Cells Training. “We have an unprecedented passion for stem cell research and its potential for medical revolutions in our world, which is why we are trying our best to make it accessible in every country possible.”

Stem Cells Training has the endorsement of prestigious medical schools and verification of their clinical stem cells research. Their internationally sourced faculty emulates a diverse and talented group of researchers whom are renowned for their groundbreaking work in the area of stem cell research.

Above all, Stem Cells Training has worked to be the torchbearer for Regenerative Medicine and Cellular Therapies to close to 3,000 physicians worldwide.

“Though we’ve already reached thousands, holding seminars in hospitals globally will provide us with an even better avenue for spreading our knowledge and expertise,” said Benito Novas. “Spread the word on the availability of ours upcomings training dates, and visit our website for registering for comprehensive Stem Cells Training education and practical application.”

Officially called “Practical Stem Cell Training Course in a Clinical Environment,” time is running out to register.

For more information, visit:


For Immediate Release: January 18, 2017
Contact: Mr Benito Novas. CEO and Founder Global Stem Cells Group


Punjab, India – Stem Cell Center Inc., a subsidiary of the Global Stem Cells Group, a group of international companies each dedicate to facilitating stem cell research and medicine, this week announced they will officially open the doors to their new Stem Cell Center in India this January 20th. The facility will be their 3rd Stem Cell Center in Asia, previously in Seoul and Manila, and now India. The official address is Cell Center SCO no. 13, Peer Muchalla, Zirakpur, Dist Mohali Punjab.

Borne from a passion for spreading the techniques and access to stem cell medicine and research across the world, the Stem Cell Center will focus on furthering the industry’s scientific and technological advancements to lead cutting edge stem cell development, treatments, and training.

“We are an organization of 30 members worldwide, making us the largest collective support and advisory network of Regenerative Medicine clinic and physician,” said Mr Benito Novas, Founder and Director at the Stem Cell Center. “Our center is poised to now offer regenerative medicine training to Indian physicians during the entire year.”

The Indian Stem Cell Center team was trained in their American facilities during September 2016, and completed their onsite Indian facility training at the beginning of this week.

Team members include: Dr. Satish K. Sood, MD, Dr. GyanPrakash, MBBS, PGDMCH, and Dr. Rama Sood, MD.

Adimarket, a subsidiary of the Global Stem Cells Group, provided a full Regenerative Medicine Lab for the Stem Cell Center in India.

“This center is ready to provide leading edge care and modern technology, all while incorporating the latest advancements in cellular therapies to patients worldwide,” said Dr. Rama Sood, MD, Owner of Stem Cells Center India. “Spread the word on the opening of our facility this Friday, and visit our website for getting in contact with our doctors.”

For those interested in being part of the Stem Cells Group network, visit: or contact us at


For Immediate Release: January 17, 2017
Mr Benito Novas
+1305 560 5337


Mexico City, Mexico – Global Stem Cells Group,htpp// a full-service collection of companies, each dedicated to facilitating stem cell research and medicine around the world, this week announced their founder and CEO, Mr. Benito Novas, will serve as a featured speaker in the main event of the 2017 Anti Aging Congress to be held in Mexico.

Mr. Novas will cover the “State of Regenerative Medicine: A Guide to Stem Cell Research and Therapies” during his featured event. The lecture will provide insight into stem cell research and therapies introduction, as well as the rules that presently govern this unique group of therapies in the United States, Europe, Asia, and Latin America.

“The Anti Aging Congress is a prolific international event that facilitates invaluable idea, education, and information exchange between the leading players in the world’s stem cell research industry,” said Mr. Novas. “As someone who dedicates my life to the development and expansion of stem cell benefits in every aspect of medicine, I am honored to serve as one of the keynote speakers of the event.”

February 19, Global Stem Cells Group will organize an interactive workshop for a sustained discussion about important news regarding Regenerative Medicine and clinical trials currently being administered to increase patient health.

Additionally, the group will host a hands-on training for physicians attending the event. This training will provide attendees with 12 proprietary protocols that enable participants to test degenerative diseases right from their offices. Attendees will walk away with new skills they can apply to treating and developing solutions for patients with degenerative disablements.

There are only 10 vacancies left in the hands-on training course.

The 2017 Mexican Anti Aging Congress will officially take place February 17t to 19.

For more information, or to sign-up for the stem cell application course on February 19, visit:

Global Stem Cell Group’s Stem Cell Training and N-Biotek, Inc. to Launch Post-graduate Studies Program in Stem Cell Therapies and Regenerative Medicine

Stem Cell Training and N-Biotek, Inc. have announced plans to launch a post-graduate studies program in stem cell and regenerative medicine, to be conducted in Seoul Korea in 2017.

MIAMI, JAN. 09, 2017—Stem Cell Training,Inc., a division of Global Stem Cells Group, Inc., and N-Biotek Inc have announced plans to launch a post graduate studies program in stem cell therapies and regenerative medicine in 2017.

The program will include Seven days of intensive, interactive training coursework with classroom instruction and laboratory practice through didactic lectures, hands-on practical experience in laboratory protocols and relevant lessons in regulatory practices. N-Biotek’s Chief Scientific Officer and Other leading Scientists will teach the coursework and perform laboratory instruction, accompanied by a series of guest lecturers from the Global Stem Cells Group faculty of scientists.

Attendees will receive hands-on training in techniques for a variety of laboratory processes, and gain insight into the inner workings of a cGMP laboratory and Korean FDA registered tissue bank. Regenerative medicine experts with more 15 years of experience in the field will train attendees and provide the necessary tools to implement regulatory and clinical guidelines in a cGMP laboratory setting

The graduate course is to be four times in Seoul in March 2017.

Course details, objectives and instruction include:
● Laboratory Training
● Hands-On Training
● Plating Stem Cells
● Harvesting and Freezing stem cells (perform counts and flow)
● Gram Stain
● Trypan
● Mycoplasma
● Gowning to enter cleanroom
● Flow Cytometry
● Endotoxin
● Sterility
● Environmental monitoring
● Calibration and PM
Didactic Lectures will include:
● Stem Cell Biology
● Cell Culture
● Trypsin
● Plating
● Flow Cytometry
● Gram Stain
● Trypan
● Potency (differentiation)
● Cryopreservation
● Quality control: endotoxin, sterility, mycoplasma
● Gowning to enter cleanroom
● Cleanroom Maintenance
● Environmental monitoring
Laboratory Protocols
For additional information, visit the Stem Cell Training, Inc. website, email info(at)stemcelltraining(dot)net, or call 305-560-5337
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions. With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine.
Global Stem Cells Groups corporate mission is to make the promise of Regenerative medicine a reality for patients around the world. With each of GSCGs six operating companies focused on a separate research-based mission, the result is a global network of state-of-the-art stem cell treatments.
About Stem Cell Training, Inc.:
Stem Cell Training, Inc. is a multi-disciplinary company offering coursework and training in 35 cities worldwide. Coursework offered focuses on minimally invasive techniques for harvesting stem cells from adipose tissue, bone marrow and platelet-rich plasma. By equipping physicians with these techniques, the goal is to enable them to return to their practices, better able to apply these techniques in patient treatments.
The company’s training courses are designed to make the best use of stem cell technology available to treat various diseases in a manner that is accessible to everyone. Stem Cell Training, Inc.’s mission is to introduce the promising world of cellular medicine to everyone who can benefit from its application, and to provide high quality, effective and efficient training that complies with the highest medical standards to physicians worldwide.